Return to Search
EN
Treatment for bone marrow cancer is highly individualized for each patient and depends on numerous factors, including the type, stage, extent of the cancer, and the patient's overall health. The primary goals of treatment may include curing the cancer, stopping or delaying its progression, or improving quality of life by alleviating symptoms. Remission is defined as the state where no abnormal cells are detected in the blood or bone marrow.
The main treatment methods for bone marrow cancers are as follows:
* Chemotherapy: This is a drug therapy aimed at killing cancer cells or preventing their proliferation. Various chemotherapy drugs can be administered intravenously or orally.
* Targeted Therapies: These are drugs developed to target specific genetic or molecular mechanisms responsible for the growth and survival of cancer cells, or markers on the surface of these cells. These treatments can also be administered orally or intravenously, depending on the nature of the drug. Each medication has its unique mechanisms of action and potential side effects.
* Stem Cell Transplant: This can be a treatment option in certain cases, but not every patient is a candidate for a transplant. Particularly in acute leukemias, a stem cell transplant may be recommended for patients with high-risk factors after the bone marrow has normalized following chemotherapy. In chronic leukemias, transplant is not the initial treatment choice and is evaluated based on the disease's progression. Prior to transplantation, high-dose chemotherapy is required to suppress or destroy the patient's existing bone marrow.
How is Bone Marrow Cancer Treated?
The main treatment methods for bone marrow cancers are as follows:
* Chemotherapy: This is a drug therapy aimed at killing cancer cells or preventing their proliferation. Various chemotherapy drugs can be administered intravenously or orally.
* Targeted Therapies: These are drugs developed to target specific genetic or molecular mechanisms responsible for the growth and survival of cancer cells, or markers on the surface of these cells. These treatments can also be administered orally or intravenously, depending on the nature of the drug. Each medication has its unique mechanisms of action and potential side effects.
* Stem Cell Transplant: This can be a treatment option in certain cases, but not every patient is a candidate for a transplant. Particularly in acute leukemias, a stem cell transplant may be recommended for patients with high-risk factors after the bone marrow has normalized following chemotherapy. In chronic leukemias, transplant is not the initial treatment choice and is evaluated based on the disease's progression. Prior to transplantation, high-dose chemotherapy is required to suppress or destroy the patient's existing bone marrow.